Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Anti–ErbB-2 mAb therapy requires type I and II interferon... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Anti–ErbB-2 mAb therapy requires type I and II interferons and synergizes with anti–PD-1 or anti-CD137 mAb therapy
0
Authors
John Stagg
7 more
John Stagg
•
Sherene Loi
5 more
•
Mark Smyth
Published
April 11, 2011
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to comment
Add a comment...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Proceedings of the National Academy of Sciences
Topics
Biology
Biochemistry
Medicine
Cancer Oncology
Immunology
Show all topics
DOI
10.1073/pnas.1016569108
